Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
Communities Across the U.S. Unite in 10‑Week Challenge to Support Blood Cancer Patients
Communities Across the U.S. Unite in 10‑Week Challenge to Support Blood Cancer Patients
News
Blood Cancer United Named to Inaugural “Best Companies for Working with Cancer” Index
Blood Cancer United® has been named one of the inaugural Best Companies for Working with Cancer, a national recognition from Cancer and Careers, the l…
News
FDA Expands Approval of Chemoimmunotherapy Combination for People with Classical Hodgkin Lymphoma
Research funded by Blood Cancer United helped establish the importance of the PD‑1 pathway in classical Hodgkin lymphoma—a foundational insight that l…
News
Vanessa Bayer to Headline 2026 Leukemia Ball
Blood Cancer United ® will welcome Saturday Night Live alum, actress, comedian, producer and pediatric blood cancer survivor Vanessa Bayer to headline…
News
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
Part of the Blood Cancer United Dare to Dream Project, the collaboration serves a dual purpose: empowering patients with their health-related data and…
News
Bob Ross-Inspired “America’s Most Artistic Kid” Competition Shines a Light on Blood Cancer United
Blood Cancer United is honored to be the beneficiary of this year’s America’s Most Artistic Kid competition, presented by Bob Ross Inc. and Colossal, …
News
FDA Approves Combination Treatment for Multiple Myeloma
Blood Cancer United has played a long-term role in supporting the foundational research that paved the way for this approval. Over more than a decade,…
News
Big Climb Takes Communities Across America to New Heights In Support of Cancer Patients
Big Climb Takes Communities Across America to New Heights In Support of Cancer Patients
News
FDA OKs the First All-Oral, Time‑Limited Treatment Option for Adults Newly Diagnosed with Most Common Form of Leukemia
A major focus of Blood Cancer United's work is supporting time‑limited treatments like this new acalabrutinib approval that are effective but do not r…
News
FDA Expands CAR T Approval to Include Patients with Rare, Aggressive Type of Non-Hodgkin Lymphoma
Blood Cancer United provided funding for the clinical trial that led to the original approval of axi-cel through its Therapy Acceleration Program® and…
News
Blood Cancer United Applauds Passage of Vital Policies to Support Kids with Cancer
Children with cancer will soon have faster access to critical care
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
